中药治疗高脂血症研究进展
Advances in Traditional Chinese Medicine for Hyperlipidemia
DOI: 10.12677/tcm.2025.1411707, PDF,   
作者: 吴凯文:黑龙江中医药大学研究生院,哈尔滨 黑龙江;王凤儒*:黑龙江中医药大学附属第一医院,哈尔滨 黑龙江
关键词: 降脂药物高脂血症研究进展中药治疗Lipid-Lowering Drugs Hyperlipemia Advances in Research Traditional Chinese Medicine Treatment
摘要: 近年来,我国高脂血症的患病率及检出率正在逐步升高,其是心血管疾病的致病危险因素,严重损害患者身心健康,而西医降脂有诸多副作用,越来越多的研究证明,中药降脂的特点作用确切,基于此,中药降脂势在必行。本文对中药治疗高脂血症研究进展按降脂中药基本功效的不同分类进行综述,希望为中医药调节血脂异常提供新思路,为中药组方及中药复方制剂提供有力参考。
Abstract: In recent years, the prevalence and detection rate of hyperlipidemia in China have been progressively increasing. As a pathogenic risk factor for cardiovascular diseases, it significantly impairs patients’ physical and mental health. While Western lipid-lowering therapies often carry various side effects, growing research has confirmed the definite efficacy of Traditional Chinese Medicine (TCM) in reducing lipid levels. Given this, the adoption of TCM for lipid management is imperative. This article reviews advances in TCM research on hyperlipidemia treatment by categorizing lipid-lowering Chinese herbs according to their fundamental therapeutic effects. The aim is to provide new insights into TCM in regulating dyslipidemia and to offer valuable references for the formulation of TCM prescriptions and compound TCM preparations.
文章引用:吴凯文, 王凤儒. 中药治疗高脂血症研究进展[J]. 中医学, 2025, 14(11): 4902-4906. https://doi.org/10.12677/tcm.2025.1411707

参考文献

[1] 张澍田, 陈旻湖. 内科学[M]. 北京: 人民卫生出版社, 2023: 517.
[2] 国家卫生健康委员会疾病预防控制局. 中国居民营养与慢性病状况报告2015 [M]. 北京: 人民卫生出版社, 2015.
[3] Ference, B.A., Ginsberg, H.N., Graham, I., Ray, K.K., Packard, C.J., Bruckert, E., et al. (2017) Low-Density Lipoproteins Cause Atherosclerotic Cardiovascular Disease. 1. Evidence from Genetic, Epidemiologic, and Clinical Studies. A Consensus Statement from the European Atherosclerosis Society Consensus Panel. European Heart Journal, 38, 2459-2472. [Google Scholar] [CrossRef] [PubMed]
[4] 孟爱君. 降血脂中药研究新进展[J]. 系统医学, 2023, 8(13): 195-198.
[5] 徐芙蓉, 徐立然, 李玉杰, 等. 基于中西医临床病症特点的高脂血动物模型分析[J/OL]. 中国实验方剂学杂志, 1-12. 2025-09-18.[CrossRef
[6] 豆晓云, 江珊, 孙萌, 等. 周仲瑛从瘀热辨治高脂血症经验撷英[J]. 中医药临床杂志, 2025, 37(1): 57-61.
[7] 郭姣, 朴胜华. 从高脂血症发病低龄化趋势探讨其中医发病机制[J]. 中医药信息, 2008(6): 4-6.
[8] 周琴宜, 陶志娟, 程绍民, 等. 中医药治疗高脂血症的临床研究进展[J]. 内蒙古中医药, 2025, 44(6): 161-163.
[9] Kim, J., Sim, H.A., Jung, D.Y., Lim, E.Y., Kim, Y.T., Kim, B.J., et al. (2019) Poria cocus Wolf Extract Ameliorates Hepatic Steatosis through Regulation of Lipid Metabolism, Inhibition of ER Stress, and Activation of Autophagy via AMPK Activation. International Journal of Molecular Sciences, 20, Article No. 4801. [Google Scholar] [CrossRef] [PubMed]
[10] 张力文, 阮云乐, 王加朋, 等. 泽泻的化学成分和药理作用研究进展[J]. 上海中医药大学学报, 2025, 39(1): 99-104.
[11] Lee, C.W., Seo, J.Y., Kim, S., Lee, J., Choi, J.W. and Park, Y.I. (2017) Corn Silk Maysin Ameliorates Obesity in Vitro and in Vivo via Suppression of Lipogenesis, Differentiation, and Function of Adipocytes. Biomedicine & Pharmacotherapy, 93, 267-275. [Google Scholar] [CrossRef] [PubMed]
[12] 王增武, 郭远林. 中国血脂管理指南(基层版2024年) [J]. 中国循环杂志, 2024, 39(4): 313-321.
[13] 黄玲, 陈俞婷, 潘尚领, 等. 火麻仁化学成分、药理作用和临床应用研究进展[J]. 广西科学院学报, 2025, 41(2): 157-169.
[14] 刘湉, 李烨, 张春红, 等. 郁李仁化学成分及药理学研究进展[J]. 安徽中医药大学学报, 2020, 39(6): 93-96.
[15] Lai, C.S., Ho, M.H., Tsai, M.L., Li, S., Badmaev, V., Ho, C., et al. (2013) Suppression of Adipogenesis and Obesity in High-Fat Induced Mouse Model by Hydroxylated Polymethoxyflavones. Journal of Agricultural and Food Chemistry, 61, 10320-10328. [Google Scholar] [CrossRef] [PubMed]
[16] 关徐涛, 杨鹤年, 张津铖, 等. 陈皮的化学成分和药理作用研究进展[J]. 中华中医药学刊, 2024, 42(6): 41-49+266.
[17] Musolino, V., Gliozzi, M., Carresi, C., et al. (2017) Lipid-Lowering Effect of Bergamot Polyphenolic Fraction: Role of Pancreatic Cholesterol Ester Hydrolase. Journal of Biological Regulators and Homeostatic Agents, 31, 1087-1093.
[18] 赵悦, 左军, 胡晓阳, 等. 山楂叶和山楂果的化学成分及药理作用研究进展[J]. 中医药导报, 2025, 31(8): 145-151.
[19] 舒丽梅, 王姝雯, 白旭峰, 等. 山楂叶黄酮类成分药理作用及机制研究进展[J]. 中药材, 2024, 47(12): 3192-3199.
[20] 孙卓, 刘龙涛. 山楂叶总黄酮心血管药理作用进展[C]//世界中医药学会联合会老年医学专业委员会, 中国中西医结合学会慢病防治与管理专业委员会. 世界中医药学会联合会老年医学专业委员会、中国中西医结合学会慢病防治与管理专业委员会2019学术年会论文摘要集. 北京: 中国中医科学院西苑医院, 2019: 49-50.
[21] Park, W.Y., Song, G., Noh, J.H., Kim, T., Kim, J.J., Hong, S., et al. (2021) Raphani Semen (Raphanus sativus L.) Ameliorates Alcoholic Fatty Liver Disease by Regulating De Novo Lipogenesis. Nutrients, 13, Article No. 4448. [Google Scholar] [CrossRef] [PubMed]
[22] 蒋长兴, 蒋顶云, 熊清平, 等. 鸡内金多糖对高脂血症大鼠血脂、血液流变学及氧化应激指标的影响[J]. 中药药理与临床, 2012, 28(5): 75-78.
[23] 葛锋, 王艳, 王剑平, 等. 红曲中主要活性成分的研究[J]. 昆明理工大学学报(自然科学版), 2012, 37(2): 61-64.
[24] 周香珍, 林书发, 何书华. 红曲药学评价研究进展[J]. 中国现代中药, 2016, 18(7): 936-941.
[25] 蒋沅岐, 董玉洁, 周福军, 等. 红曲的化学成分、药理作用及临床应用研究进展[J]. 中草药, 2021, 52(23): 7379-7388.
[26] Lee, H., Kim, M.H., Jin, S.C., Han, J.M., Park, J.H. and Yang, W.M. (2021) Lipolytic and Lipophagic Effects of Pinellia ternata Pharmacopuncture on Localized Adiposity. Evidence-Based Complementary and Alternative Medicine, 2021, Article ID: 7347639. [Google Scholar] [CrossRef] [PubMed]
[27] 雍秋清, 张博达. 半夏成分及现代药理作用研究进展[J/OL]. 环球中医药, 1-13.
https://link.cnki.net/urlid/11.5652.R.20251020.1652.072, 2025-09-25.
[28] 高云芳, 陈超, 张海祥, 等. 桔梗总皂苷对大鼠高脂血症的影响[J]. 中草药, 2000(10): 46-47.
[29] 于刚. 降血脂中药筛选及桔梗总皂苷降血脂活性研究[D]: [硕士学位论文]. 重庆: 西南大学, 2009.
[30] 陈梅霞, 苏洁, 张玥莉, 等. 银杏叶提取物与银杏黄酮对高脂血症大鼠血脂水平影响的比较研究[J]. 中国新药杂志, 2014, 23(7): 833-838.
[31] 黄菊青, 林斌, 徐庆贤, 等. 绞股蓝茶饮对高脂血症大鼠脂质代谢和肠道菌群的影响[J]. 中国食品学报, 2018, 18(6): 27-32.
[32] 孙嘉莉, 赵文燕, 朱东亮, 等. 沙棘果皮渣总黄酮体内外降血脂活性研究[J]. 食品工业科技, 2024, 45(24): 353-363.
[33] 孔天宇, 赵岩, 高玲, 等. 沙棘活性成分、生物功能及综合利用研究进展[J/OL]. 北方园艺, 1-14.
https://link.cnki.net/urlid/23.1247.s.20250825.1029.006, 2025-09-25.
[34] Borén, J., Chapman, M.J., Krauss, R.M., Packard, C.J., Bentzon, J.F., Binder, C.J., et al. (2020) Low-Density Lipoproteins Cause Atherosclerotic Cardiovascular Disease: Pathophysiological, Genetic, and Therapeutic Insights: A Consensus Statement from the European Atherosclerosis Society Consensus Panel. European Heart Journal, 41, 2313-2330. [Google Scholar] [CrossRef] [PubMed]
[35] 倪勇, 武翔, 孔祥海, 等. 老年急性脑梗死患者红细胞分布宽度和血脂代谢指标与颈动脉粥样硬化斑块稳定性的关系[J]. 中华老年心脑血管病杂志, 2025, 27(9): 1229-1232.
[36] 刘梅林. 常用调脂药物的分类、用途及主要副作用(续3) [J]. 中国循环杂志, 2010, 25(1): 69-70.